Hypophosphatemia and pre-infusion thrombocytopenia as biomarkers for CRS and ICANS after CAR T therapy

Bone Marrow Transplant. 2023 Nov;58(11):1267-1269. doi: 10.1038/s41409-023-02083-4. Epub 2023 Aug 14.

Authors

Kenneth Barker¹, Shannon Koza², Emmanuel Katsanis^{2

3

4}, Muhammad Husnain^{5

2}

Affiliations

¹ Department of Medicine, University of Arizona, Tucson, AZ, USA. Kennybarker@arizona.edu.
² University of Arizona Cancer Center, Tucson, AZ, USA.
³ Departments of Immunobiology, Medicine, and Pathology, University of Arizona, Tucson, AZ, USA.
⁴ Department of Pediatrics, University of Arizona, Tucson, AZ, USA.
⁵ Department of Medicine, University of Arizona, Tucson, AZ, USA.

PMID: 37580398
DOI: 10.1038/s41409-023-02083-4

No abstract available

Publication types

Letter

MeSH terms

Biomarkers
Humans
Hypophosphatemia* / etiology
Immunotherapy, Adoptive
Neurotoxicity Syndromes*
Receptors, Chimeric Antigen*
Thrombocytopenia* / etiology

Substances

Receptors, Chimeric Antigen
Biomarkers